| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Early Stage, Seed, Series A |
| Investing | Australia • Germany • France • Spain |
| Investment Range | €50,000 - €1,000,000 |
Insurtech Gateway is a venture capital firm that specializes as an incubator and investor in the early-stage insurtech sector.
They stand out as the only investor with an FCA (Financial Conduct Authority) authorized incubator combined with an investment fund. Their initiative is designed to be the most expedited avenue for developing and launching insurtech ideas. This unique approach enables them to support start-ups from early concept stages through rapid growth and scaling to Series A funding rounds and beyond.
With a maximum investment of £1,000,000 and a minimum of £50,000, Insurtech Gateway is well-positioned to finance innovative companies during crucial growth phases. Their expertise is evident in their specialized support for mission-driven founders worldwide, guiding them through building sustainable partnerships with insurers, regulators, and co-investors.
By actively engaging in sectors such as cryptocurrency protection, climate change tracking through advanced flood models, and providing insurance access to previously uncovered communities, they show a deep commitment to leveraging technology and insurance to drive societal transformation.
Furthermore, the firm offers founders the opportunity for confidential, exploratory discussions even in the earliest stages of idea formation.
Insurtech Gateway operates with a clear purpose: to catalyze change in the world by enabling and securing emerging sectors through insurtech innovation. The firm's headquarter is located at 32 Blackfriars Road, London, England SE1 8PB, GB, demonstrating their established presence in a global hub for financial and technological entrepreneurship.
We invest in early-stage Insurtech companies. Insurtech Gateway is the only investor with its own FCA authorised incubator + fund. The fastest place to build and launch an insurtech idea. The Gateway Fund supports the portfolio post-incubation, as they enter a phase of rapid growth and scale-up, to Series A and beyond.

